Cancer screening practices among racially and ethnically diverse breast cancer survivors: results from the 2001 and 2003 California Health Interview Survey
Cancer screening practices among racially and ethnically diverse breast cancer survivors: results from the 2001 and 2003 California Health Interview Survey
复制标题
DOI：
10.1007/s11764-009-0102-5
复制
发表时间：
2010-03-01
影响因子：
3.7
通讯作者：
Hawley, Sarah
中科院分区：
文献类型：
--
作者：
Breslau, Erica S.;Jeffery, Diana D.;Hawley, Sarah
接受乳腺癌治疗的女性罹患第二种或新的癌症的风险增加。这项研究调查了不同种族和民族的女性乳腺癌幸存者(BCS)和没有癌症病史的女性，与乳房X光检查、巴氏检查(Pap)、家庭粪便潜血测试(FOBT)和内窥镜(柔性乙状结肠镜、结肠镜、直肠镜)筛查行为相关的行为和医疗保健利用情况。方法2001年和2003年加州健康访谈调查(CHIS)的数据被用来检查自我报告的BCS(n=1,502)和没有癌症病史的女性(n=31,911)的筛查做法。在BCS中，拉美裔报告常规乳房X光检查筛查率最低(84.2%比68.9%；P<；0.05)，但巴氏试验筛查率最高(95.4%比85.4%；P>；0.01)。白人和亚裔BCS报告的内窥镜检查比对照人群多(58.9%比46.5%；P<；0.001；61.2%比38.4%；P<；0.05)。调整人口学、社会经济和健康状况差异后，BCS的筛查率高于无癌症史的女性(优势比[OR]1.97；95%可信区间[95%CI]1.58~2.46)、巴氏试验(OR 1.44；95%CI 1.22~1.70)和内窥镜检查(OR 1.35；95%CI 1.16~1.58)，但FOBT的筛查率并不高于无癌症病史的女性。缩小这些差异对于减少差异是至关重要的。对于癌症幸存者来说，BCS筛查指南的必要性仍然是一个高度优先的问题。幸存者将受益于治疗后所有癌症的筛查频率。
Introduction Women treated for breast cancer are at increased risk for developing second or new cancers. This study examined behavioral and health care utilization practices associated with screening behaviors for mammography, Papanicolaou (Pap), home fecal occult blood test (FOBT) and endoscopy (flexible sigmoidoscopy, colonoscopy, proctoscopy) among racially and ethnically diverse female breast cancer survivors (BCS) and women without a cancer history.Methods Data from the 2001 and 2003 California Health Interview Survey (CHIS), a random-digit dial population-based survey of adult respondents was used to examine self-reported screening practices of BCS (n=1,502) and women without a cancer history (n=31,911).Results Compared to women without a cancer history, BCS reported more recent screening for all tests. Among BCS, Hispanics reported lowest screening for routine mammography (84.2% versus 68.9%; P < 0.05) but highest screening for Pap test (95.4% versus 85.4%; P > 0.01). White and Asian BCS reported more endoscopic examinations (58.9% versus 46.5%; P < 0.001; 61.2% versus 38.4%; P < 0.05) than the comparison population. After adjustment for demographic, socioeconomic, and health status differences, screening rates for BCS showed higher mammography use (odds ratio [OR] 1.97; 95% confidence interval [95% CI] 1.58-2.46), Pap test (OR 1.44; 95% CI 1.22-1.70), and endoscopic use (OR 1.35; 95% CI 1.16-1.58), but not higher for FOBT.Conclusions Even though BCS generally had higher cancer screening rates than women without a cancer history, racial/ethnic differences exist among the type of test received. Narrowing these differences is essential to lessen disparities.Implications for cancer survivors The need for screening guidelines for BCS remains a high priority. Survivors would benefit from the frequency of screening for all cancers post-treatment.